Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.
The presence of more than one human papillomavirus (HPV) genotype may influence the duration of prevalently detected infections. This analysis included 1,646 infections detected at enrollment in 980 women from the Guanacaste, Costa Rica, cohort who were actively followed up every 6-12 months for up to 8 years. We categorized HPV infections as single or multiple types. Persistence of infections was estimated using discrete-time survival analysis. The difference between the duration of single and that of concurrent multiple type-specific prevalent HPV infections was not significant (P = .9; log-rank test). Concurrent, prevalent detection of additional HPV types did not change the likelihood of viral persistence.
Center for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts, USA. gastin@post.harvard.edu
Nicole G
NG
Campos
Ana Cecilia
AC
Rodriguez
Philip E
PE
Castle
Rolando
R
Herrero
Allan
A
Hildesheim
Hormuzd
H
Katki
Jane J
JJ
Kim
Sholom
S
Wacholder
Jorge
J
Morales
Robert D
RD
Burk
Mark
M
Schiffman
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D003364:Costa Rica / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000821:virology*; D012008:Recurrence; D016019:Survival Analysis; D055815:Young Adult
J Natl Cancer Inst. 2008 Apr 2;100(7):513-7
18364507
BMJ. 2009 Jul 28;339:b2569
19638649
J Infect Dis. 2005 Jun 1;191(11):1796-807
15871111
J Infect Dis. 2008 May 15;197(10):1436-47
18419547
Rev Panam Salud Publica. 1997 May;1(5):362-75
9180057
Br J Cancer. 2009 Apr 7;100(7):1184-90
19293802
J Infect Dis. 2001 Jan 1;183(1):8-15
11087198
J Pathol. 1999 Sep;189(1):12-9
10451482
J Infect Dis. 2006 Nov 1;194(9):1291-9
17041856
J Infect Dis. 2007 Jun 1;195(11):1582-9
17471427
J Med Virol. 2002 Nov;68(3):417-23
12226831
Virology. 2005 Jun 20;337(1):76-84
15914222
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1274-80
16835323
Int J Cancer. 2009 Nov 1;125(9):2151-8
19585494
J Natl Cancer Inst. 2010 Mar 3;102(5):315-24
20157096